AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (599.6 KB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Editorial | Open Access

Harnessing the STING pathway for HCC treatment

Carmen Chak-Lui Wong1,2,3,4,* ( )Cerise Yuen-Ki Chan1,2,3,*Helen Do-Gai Xue1,2,3,*Chun-Ming Wong1,2 ( )
Department of Pathology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China
State Key Laboratory of Liver Research, The University of Hong Kong, Hong Kong, China
Centre for Oncology and Immunology, Hong Kong Science Park, Hong Kong, China
Department of Clinical Oncology, Shenzhen Key Laboratory for Cancer Metastasis and Personalized Therapy, The University of Hong Kong-Shenzhen Hospital, Shenzhen 518053, China

*These authors contributed equally to this work.

Show Author Information

References

【1】
【1】
 
 
Cancer Biology & Medicine
Pages 1423-1430

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Wong CC-L, Chan CY-K, Xue HD-G, et al. Harnessing the STING pathway for HCC treatment. Cancer Biology & Medicine, 2025, 22(12): 1423-1430. https://doi.org/10.20892/j.issn.2095-3941.2025.0434

95

Views

1

Downloads

1

Crossref

1

Web of Science

1

Scopus

Received: 30 July 2025
Accepted: 05 November 2025
Published: 15 December 2025
©2025 The Authors.

Creative Commons Attribution-NonCommercial 4.0 International License